Kathleen Goetz
Director · Aurinia Pharmaceuticals Inc.
Individual
- 2026
- Jun 8, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kathleen Goetz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Tang - $25.14M in AUPH purchases and sales in the last 12 months
- Stephen P. Robertson - $546K in AUPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kathleen Goetz?
Kathleen Goetz is a corporate insider, tracked as Director of Aurinia Pharmaceuticals Inc. (AUPH). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kathleen Goetz last file a Form 4?
The only primary Form 4 on record is dated 8 June 2026.